Zheng Guo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Potential Targeted Therapy for Type I Diabetes: Monoclonal Antibodies

Innovative study on mice leads to a potential targeted monoclonal antibody therapy to manage Type I diabetes. Study highlights need for human version of antibody.

United statesDevi kasinathanZheng guoDax fuJohns hopkins university school of medicineSurface zntReverses autoimmune diabetesJohns hopkins medicineDrug shelters pancreas cellsImmune systemNew experimental drugJohns hopkins university schoolImmune system attackBeta cellsMonoclonal antibodiesTargeted therapy

Experimental type 1 diabetes drug shelters pancreas cells from immune system attack

Experimental type 1 diabetes drug shelters pancreas cells from immune system attack
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

United statesChandan sonaMaria golsonDax fuG william wongAaron michelsLiping yuZheng guoDylan sarverJohns hopkinsDevi kasinathanShumei yunMatthew poyNational institutes of healthDrug administrationJohns hopkins university school of medicine

Drug appears to reverse type 1 diabetes in mice

A new type 1 diabetes drug hides insulin-making beta cells from the immune system and shields them from attack, a study with mice shows.

United statesDax fuZheng guoDevi kasinathanJohns hopkinsNational institutes of healthJohns hopkins university school of medicineUniversity of marylandDrug administrationUniversity of coloradoJohns hopkins university schoolNational institutes

Experimental drug shields pancreas from type 1 diabetes attack

Experimental drug shields pancreas from type 1 diabetes attack
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesG william wongDax fuDylan sarverMaria golsonDevi kasinathanZheng guoJohns hopkinsChandan sonaLiping yuMatthew poyAaron michelsShumei yunUniversity of coloradoDrug administrationUniversity of maryland

Experimental Type 1 Diabetes Drug Shelters Pancreas Cells From Immune System Attack

Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1

United statesJohns hopkinsAaron michelsMaria golsonZheng guoDax fuMatthew poyDylan sarverLiping yuChandan sonaG william wongShumei yunDevi kasinathanJohns hopkins university school of medicineDrug administrationNational institutes of health